FURI | Spring 2026

Optimizing 3D Printed Scaffolds for Immune-Protected Cell Therapy

Drug delivery devices often fail because the immune system attacks them, causing scarring that blocks function. The researcher proposes developing and optimizing biocompatible 3D-printed scaffolds, such as polystyrene, to safely house therapeutic cells, maintain their viability, and support long-term drug or nutrient delivery without triggering immune rejection. This approach addresses a critical gap in tissue engineering by translating scaffold design into functional therapies, demonstrating how 3D-printed scaffolds can protect cells, enhance device longevity, and integrate into injectable formats, advancing safer and more durable treatments for chronic diseases and regenerative medicine.